These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5552928)

  • 1. [On hepatocellular damage caused by MAOI drugs].
    Barberini E; Malagoli G
    Minerva Med; 1971 Mar; 62(23):1220-4. PubMed ID: 5552928
    [No Abstract]   [Full Text] [Related]  

  • 2. The hepatic injury of monoamine oxidase inhibitors.
    Zimmerman HJ; Ishak KG
    J Clin Psychopharmacol; 1987 Aug; 7(4):211-3. PubMed ID: 3624504
    [No Abstract]   [Full Text] [Related]  

  • 3. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaphylaxis and monoamine oxidase inhibitors--the use of adrenaline.
    Fenwick MJ; Muwanga CL
    J Accid Emerg Med; 2000 Mar; 17(2):143-4. PubMed ID: 10718244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are MAOI and other psychotropic drugs really compatible?
    Man PL; Aleem A
    Br J Psychiatry; 1972 Jan; 120(554):120-1. PubMed ID: 5041510
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine.
    Sokolski KN; Brown BJ
    Ann Pharmacother; 2006 Mar; 40(3):567-70. PubMed ID: 16478812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenelzine-induced fulminant hepatic failure.
    Gómez-Gil E; Salmerón JM; Mas A
    Ann Intern Med; 1996 Apr; 124(7):692-3. PubMed ID: 8607601
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of chronic phenelzine treatment on REM sleep: report of three patients.
    Landolt HP; de Boer LP
    Neuropsychopharmacology; 2001 Nov; 25(5 Suppl):S63-7. PubMed ID: 11682276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mysterious MAOI hypertensive episodes.
    Linet LS
    J Clin Psychiatry; 1986 Nov; 47(11):563-5. PubMed ID: 3095312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphadenopathy associated with monoamine oxidase inhibitors.
    Kallab AM; Marley EM; Frei-Lahr D
    Am J Hematol; 1999 Feb; 60(2):167. PubMed ID: 9929114
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenelzine-induced myocardial injury: a case report.
    Ngo AS; Ho RY; Olson KR
    J Med Toxicol; 2010 Dec; 6(4):431-4. PubMed ID: 20652662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke resulting from a rapid switch from phenelzine to tranylcypromine.
    Mattes JA
    J Clin Psychiatry; 1998 Jul; 59(7):382. PubMed ID: 9714269
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP; Boyer WF; Tyler DL; Neborsky RJ
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myoclonus, hyperreflexia and diaphoresis in patients on phenelzine-tryptophan combination treatment.
    Levy AB; Bucher P; Votolato N
    Can J Psychiatry; 1985 Oct; 30(6):434-6. PubMed ID: 4063940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.